Department of Psychiatry Division of Research Annual Report Calendar Year

2013

Department of Psychiatry Division of Research

Annual Research Report for the Year 2012 Prepared 9/30/14 Introduction: The Department of Psychiatry at SUNY Upstate Medical University continued to be very productive over the past calendar year. The following document is a compendium of the research activities of Department faculty members and trainees. This report includes the listing, by faculty member or trainee, of activities in the following areas: - Research Grants - Research Publications - Research Presentations at National or International Conferences The report describes the Department of Psychiatry’s growing success and accomplishments in these areas. Please contact Jackie Hattersley at 464-3130 if we have inadvertently left out or misstated any details related to research activities. The Research Division will issue its next report on calendar year 2014 in the Spring of 2015. Congratulations to all of the faculty, staff and trainees who contributed to the impressive research accomplishments of our department.

2

Department of Psychiatry Division of Research

Annual Research Report 2013

Prepared 9/30/14 Table of Contents

Introduction ………………………………………………………………. page

2

Research Grants ………………………………………………………… page

4

Research Publications ……………………………………………………page 15 Research Presentations ………………………………………………… page 31

3

Grants ANTSHEL, Kevin Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Computerized Cognitive Remediation in Adolescents with VCFS 2010-2014

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Biomarkers for Psychosis in Velocardiofacial Syndrome 2002-2014 $1,814,264 NIMH Co-Investigator

NIMH Co-Investigator

BATKI, Steven L. Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

DrugAbuse Treatment/Services Research Training Program 4/1/10-3/31/14 $318,108 NIH/NIDA Co-Director and Faculty Mentor

COMAN, Ioana Title of Grant:

Computer-Based Cognitive Remediation In Adolescents With Vcfs (PI. Wendy Kates, PhD) Period of Funding: 22-MAY-2009 through 30-APR-2014 Amount of Funding: $265,999 (FY 2012) Funding Source: NATIONAL INSTITUTE OF MENTAL HEALTH Position on Grant: Research Scientist Title of Grant:

Biomarkers for Psychosis in Velocardiofacial Syndrome (PI. Wendy Kates, PhD) Period of Funding: 2/19/02 – 1/31/16 Amount of Funding: $768,323 (FY 2012) Funding Source: National Institute of Mental Health Position of Grant: Co-Investigator Title of Grant:

Biomarkers for Psychosis in Velocardiofacial Syndrome – Supplement (awarded in April 2013) (PI. Wendy Kates, PhD) Period of Funding: 2013-2016 Amount of Funding: $286,636 (for the whole period) Funding Source: National Institute of Mental Health Position on Grant: Co-Investigator 4

DEWAN, Mantosh Title of grant: Period of funding: Amount of funding: Funding source: Position on grant:

Genomic Psychiatry Cohort 2008-2013 $1,099,000 USC/National Institutes of Mental Health Co-PI

FARAONE, Stephen Title of Grant: Period of Funding: Amount of Funding: Funding Source : Position on Grant:

ADHD Molecular Genetics Network Conference 4/1/2009-3/31/2015 Direct Costs for funding period: $152,000 NIMH PI

Title of Grant:

The Intergenerational Transmission of Trauma from Terror: A Developmental Approach Period of Funding: 4/1/08-7/31/13 Amount of Funding: $1,586,967 total costs for funding period Funding Source: NICHD Position on Grant: PI Title of Grant:

2/2 Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan Period of Funding: 9/30/08-9/29/14 Amount of Funding: $800,000 direct costs for funding period Funding Source: NIMH Position on Grant: Investigator Title of Grant:

A New Approach to Mental Health Phenotypes in Family Genomewide Association Scans Period of Funding: 12/01/09 – 11/30/13 Amount of Funding: $368,255 for funding period to HSPH Funding Source: Harvard School of Public Health Position on Grant : Subaward PI Title of Grant:

Translational Studies on the Role of Developmental Pyrethroid Exposure in ADHD Period of Funding: 9/2010-6/30/2013 Amount of Funding: $1,598,483 total cost to primary UMDNJ Funding Source : UMDNJ Position on Grant : Subaward PI Title of Grant:

Disruption of an epigenetic locus controlling EAAC1 expression in schizophrenia Period of Funding: 2/25/12-1/31/14 Amount of Funding: $319,000 total cost 5

Funding Source: Position on Grant :

NIMH Investigator

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Biomarkers for Psychosis in Velocardiofacial Syndrome 3/01/02-5/31/17 $768,323 total funding NIMH Investigator

Title of Grant:

1/4 Psychiatric GWAS Consortium: Genomic Follow-up Next-Gen Sequencing & Genotyping Period of Funding: 5/10/2012-11/30/2015 Amount of Funding: $491,979 total funding to primary UNC Funding Source: University of North Carolina Position on Grant : Subaward PI

1b.

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Quantifying the impact of rare mutations on ADHD 6/1/12-4/30/2017 $677,984 total funding to Broad Institute Broad Institute Subaward PI

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Adult ADHD Research Dissemination Partnership Initiative 1/1/13-1/31/16 Total funding for funding period: $900,000 AHRQ PI

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

ADHD biotypes using genetic and imaging approaches 8/1/13-7/31/18 Total funding for funding period: $457,613 NIH Subaward PI

PENDING IN 2013: Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Preclinical efficacy study of amiloride in treating ADHD 9/1/2013-8/31/2016 $600,000 direct costs for grant period-not funded NIMH Co-PI

Title of Grant:

Susceptibility genes for ADHD: From genes to proteins & drug targets Period of Funding: 9/1/2013-8/31/2017 Amount of Funding: $600,000 total for grant period-Not funded Funding Source: NIMH Position on Grant : PI 6

Title of Grant:

Longitudinal Family/Molecular Genetic Study to Evaluate Research Domain Criteria. Period of Funding: 5/1/14-3/31/19 Amount of Funding: $ 1,840,413 total for grant period-funding pending Funding Source: NIMH Position on Grant : Co-PI Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

ADHD & ASDs: From genes to protein targets 7/1/2014-6/30/2018 $975,000 costs for grant period-Not funded NIMH PI

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

PTSD & ADHD: Clinical applications 6/1/2014-5/31/2017 $862,124 costs for grant period-Not funded VA merit review PI

Title of Grant:

Therapeutic utility of Amiloride Hydrochloride for the treatment of adult ADHD Period of Funding: 4/1/2014-3/31/2017 Amount of Funding: $413,291 costs for grant period-Not funded Funding Source: VA merit review Position on Grant : PI Title of Grant:

Disseminating information about ADHD to primary care practitioners: a comparative study Period of Funding: 1/1/2014-12/31/2017 Amount of Funding: $1,500,000 costs for grant period-Not funded Funding Source: PCORI Position on Grant : PI Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Protein-protein interaction in ASD: implications for treatment 7/1/2013-6/30/2014 $50,000 costs for grant period-Not funded SFARI PI

FREMONT, Wanda Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Biomarkers for Psychosis in Velocardiofacial Syndrome 2002-2016 $2,695,055 NIMH (2R01MH64824-11) Co-investigator 7

Title of Grant:

Consultation and Training to Pediataricians and Primary Care Providers Period of Funding: 2010-2014 Amount of Funding: $2,400,000 Funding Source: NYS OMH Division of Children and Family Services Position on Grant: Co-investigator Title of Grant:

Computer-Based Cognitive Remediation in Adolescents with Velo-Cardio Facial Syndrome Period of Funding: 2009-1014 Amount of Funding: $1,187,307 Funding Source: NIMH (R21/R33 MHO85901) Position on Grant: Co-investigator

GLATT, Stephen J Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Sidney R. Baer, Jr. Prize for Schizophrenia Research 10/29/10-indefinite $40,000 NARSAD: The Brain and Behavior Research Fund Principal Investigator

Title of Grant:

Genetic Predictors of Neuropsychological and Functional Outcomes in Schizophrenia Period of Funding: 8/15/08-7/31/14 Amount of Funding: $241,861 Funding Source: NIH/NIMH Position on Grant: Co-Investigator Title of Grant:

2/2-Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan Period of Funding: 9/30/08-5/31/14 Amount of Funding: $950,000 Funding Source: NIH/NIMH Position on Grant: Principal Investigator Title of Grant:

Training Veterans to Conduct Trauma-Related Research with Fellow Veterans Period of Funding: 07/01/2011-06/30/14 Amount of Funding: $225,780 Funding Source: National Science Foundation Position on Grant: Co-Investigator Title of Grant:

Blood-Based Biomarkers for Early Autism and Autism Spectrum Disorders Period of Funding: 05/31/2012-05/30/15 Amount of Funding: $272,513 8

Funding Source: Position on Grant:

Gerber Foundation Principal Investigator

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Interactome of DRD2 Variants Conferring Risk for Schizophrenia 07/15/2013-07/14/2015 $100,000 NARSAD: The Brain and Behavior Research Fund Principal Investigator

HARGRAVE, Terri Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

CAPPC 2010 – end of 2014 ? NYSOMH Co-Investigator

KATES, Wendy Title of Grant:

Biomarkers for Psychosis in Velocardiofacial Syndrome Grant number: 2R01MH064824-11 Period of Funding: 4/2012-4/2016 This grant renewal was approved for continued funding in 2012 Amount of Funding: Total costs: $2,695,055 Funding Source: NIH/NIMH Position on Grant: Principal Investigator Title of Grant:

Computer-based Cognitive Remediation in Adolescents With Velo-Cardio-Facial Syndrome Grant Number: R21 / R33 MH085901 Period of Funding: 2009-2114 Amount of Funding: Total Direct Costs: $1,187,307. Funding Source: NIH/NIMH Position on Grant: Principal Investigator Title of Grant:

Supplement to Biomarkers for Psychosis in Velo-cardio-facial Syndrome: Fusion of fMRI and DTI Modalities in Velo-cardiofacial Syndrome Grant number: R01 MH64824-Supplement Period of funding: 7/01/13-12/31/16: Amount of funding: $147,245. Funding Source: NIH/NIMH Position on Grant: Principal Investigator

9

Title of Grant:

Behavioral and Neurophysiological Indices of the Temporal Dynamics of Visual Processing Among Persons with ASD and VCFS Grant number: N/A Period of Funding: 2012-2013 Amount of Funding: $8,748 Funding Source: Upstate / SU Hill Collaborative Grant Position on Grant: Co-Investigator (with P.I. Natalie Russo) Title of Grant:

International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome Grant number: 1-U01-MH-101719-01 Period of Funding: 2013-2017 Amount of Funding: $164,944 Funding Source: NIMH Position on Grant: Principal Investigator, SUNYsubcontract MEGNA, James Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Changes in Cognition in Response to Depression Treatment During Inpatient Psychiatric Hospitalization 2012-2013 $500 Research Foundation (principal investigator’s account) Principle Investigator

MESZAROS, Zsuzsa 1b

PENDING IN 2013: Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Brief Smoking Cessation Intervention in an Office Based Opioid Maintenance Program 09/2014 – 09/2015 $15,000 Hill Collaboration Co-PI

MORLEY, Christopher Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position of Grant:

“Collaborative Research Infrastructure” Academic Administrative Unit award 2011-2016 $800,000 Health Resources & Services Administration (HRSA) Principal Investigator

Title of Grant:

“Genomic Psychiatry Cohort” 10

Period of Funding: Amount of Funding: Funding Source: Position on Grant:

2008-2013 $3,828,698 National Institute of Mental Health (NIMH) - Subcontract to SUNY Upstate/RF (University of Southern California, primary) Co-Principal Investigator- SUNY Upstate Subaward (With Mantosh Dewan, MD)

MYLES-WORSLEY, Marina Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Disruption of an Epigenetic Locus Controlling SLC1A1 Expression in Schizophrenia R21 MH096257 Feb 1 2012 to Jan 31 2014 (Should have started Nov 2011, finally funded Feb 23, 2012) $200K in Year 1, $75K in Year 2 NIH Principle Investigator

ROANE, Henry S Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Enhanced Intensive Behavioral Services 10/1/12 – 9/30/15 $387,000 annually NYS Office of People with Developmental Disabilities Director

Title of Grant:

CN 138-603: Safety and Efficacy of Aripiprazole in the LongTerm Maintenance Treatment of Pediatric Patients with Irritability Associated with Autistic Disorders.

Period of Funding: Amount of Funding: $100,000 in patient-relatedcare costs Funding Source: Phase 3 Randomized Clinical Trial funded by Bristol-Myers Squibb Position on Grant: Principal Investigator

Title of Grant: Period of Funding: Amount of Funding: Funding Source:

Position on Grant:

Family Behavior Analysis Clinic – Community Based Services 7/1/10 to 6/30/15 $318,090 in direct costs 2009 Autism/Crisis Family Support Services grant funded by the Central New York Disabilities Service Office (CNYDSO) within the New York State Office of Mental Retardation and Developmental Disabilities. Principal Investigator

11

Title of Grant:

Using Technology to Expand and Enhance Applied Behavioral Analysis Programs for Children with Autism in Military Families Period of Funding: 10/1/11 to 9/30/15 Amount of Funding: $1,484,879 in direct costs Funding Source: FY10 Clinical Trial Award funded by the United States Department of Defense Autism Research Program of the Office of the Congressionally Directed Medical Research Programs through the Office of the United States Army (PI: Wayne Fisher) Position on Grant: Co-Investigator

SALETSKY, Ronald Title of Grant:

Weight loss in Primary Care: a translation of the Diabetes Prevention Program. Period of Funding: 2008-2013 Amount of Funding: $3,200,000 Funding Source: NIH – National Institute of Diabetes, Digestive and Kidney Diseases Position on Grant: Co-Investigator

SCHWARTZ, Thomas Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

VNS for MDD 5 year $100,000 Cyberonics Inc. Principal Investigator

SPEAR, Norman Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Ethanol intake and reinforcement in infant rats 3/1/02 - 2/28/07; 2008-2013 (Renewal) Direct costs per year: $225,000 NIAAA (RO1 (AA13098) Principal Investigator

TRIEF, Paula Title of Grant:

Weight loss in Primary Care: a translation of the Diabetes Prevention Program. Period of Funding: 9/08 - 8/13 (no cost extension 8/13-8/14) Amount of Funding: $3,200,000 (total costs) Funding Source: NIH – National Institute of Diabetes, Digestive and Kidney Diseases Position on Grant: Principal Investigator (Multiple PIs) 12

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Improving diabetes outcomes: The Diabetes Support Project 9/09 – 8/14 approx. $4,000,000 (total costs) NIH National Institute of Diabetes, Digestive and Kidney Diseases Principal Investigator

Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant:

Resilience through Multidimensional Mentoring 9/10-9/13 $289,000 (total costs at our site), with U. of Rochester NIH Co-Investigator (PI: Vivian Lewis, U of Rochester; Site PI: Steve Goodman)

Pending in 2013: Title of Grant:

Weight Loss in Persons with Mobility Impairments: A DPP Translation Study Period of Funding: 9/13 – 9/16 Amount of Funding: $1,050,000 Funding Source: CDC Position on Grant: PI YOUNGENTOB, Steven Title of Grant:

Upstate Administrative Core – as part of the Developmental Ethanol Exposure Research Center Grant #1 P50 AA017823-01 Period of Funding: 2009-2014 Amount of Funding: $281,485 Funding Source: NIH Position on Grant: Principal Investigator Title of Grant:

Fetal and Adolescent Alcohol Exposure – RC#2 as part of the Developmental Ethanol Exposure Research Center NIH/NIAAA grant 1 P50 AA017823-01 Period of Funding: 2009-2014 Amount of Funding: $960,000 Funding Source: NIH Position on Grant: Principal Investigator Title of Grant:

Fetal and Adolescent Alcohol Exposure – RC#2 as part of the Developmental Ethanol Exposure Research Center NIH/NIAAA grant 1 P50 AA017823-01 Period of Funding: 2014-2019 Amount of Funding: Total direct costs RC#2 = $875,000 Funding Source: NIH Position on Grant: PI

13

ZHANG-JAMES, Yanli Title of Grant:

Role of SLC9A9 in learning and memory behavior in Knockout mice Period of Funding: 7-1-2011 to 6-30-2013 Amount of Funding: Direct Costs for funding period: $60,000 Funding Source: NARSAD Position on Grant: PI Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Preclinical efficacy study of amiloride in treating ADHD. 9/1/2013-8/31/2016 $600,000 direct costs for grant period NIMH Co-PI

Title of Grant:

A novel inbred rat model for co-morbid inattentive ADHD and autism. Period of Funding: 12/1/2012-11/30/2014 Amount of Funding: $275,000 costs for grant period-Not funded Funding Source: NIMH Position on Grant : Investigator Title of Grant: Period of Funding: Amount of Funding: Funding Source: Position on Grant :

Amiloride Hydrochloride as an effective treatment for ADHD 4/1/2013-3/31/2015 $275,000 costs for grant period-Not funded NIMH PI

14

Publications COMAN, Ioana Matthew D Perlstein, Moeed R Chohan, Ioana L Coman, Kevin M Antshel, Wanda P Fremont, Matthew H Gnirke, Zora Kikinis, Frank A Middleton, Petya D Radoeva, Martha E Shenton, Wendy R Kates (2013): White matter abnormalities in 22q11.2 deletion syndrome: Preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis. Schizophrenia Research. 12/2013; FARAONE, Stephen Ramamurthy G, Trejo E, Faraone SV. Depression treatment in patients with coronary artery disease: a systematic review. Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.13r01509. doi: 10.4088/PCC.13r01509. Epub 2013 Oct 24. PubMed PMID: 24511449; PubMed Central PMCID: PMC3907329. Caci H, Doepfner M, Asherson P, Donfrancesco R, Faraone SV, Hervas A, Fitzgerald M. Daily life impairments associated with self-reported childhood/adolescent attentiondeficit/hyperactivity disorder and experiences of diagnosis and treatment: results from the European Lifetime Impairment Survey. Eur Psychiatry. 2014 Jun;29(5):316-23. doi: 10.1016/j.eurpsy.2013.10.007. Epub 2013 Dec 16. PubMed PMID: 24355601. Joseph N, Zhang-James Y, Perl A, Faraone SV. Oxidative Stress and ADHD: A Meta-Analysis. J Atten Disord. 2013 Nov 14. [Epub ahead of print] PubMed PMID: 24232168. Makris N, Liang L, Biederman J, Valera EM, Brown AB, Petty C, Spencer TJ, Faraone SV, Seidman LJ. Toward Defining the Neural Substrates of ADHD: A Controlled Structural MRI Study in Medication-Naive Adults. J Atten Disord. 2013 Nov 4. [Epub ahead of print] PubMed PMID: 24189200; PubMed Central PMCID: PMC4009385. Kaitz M, Rokem AM, Mankuta D, Davidov M, Faraone SV. Exposure to childhood traumas ups the odds of giving birth to daughters. Arch Womens Ment Health. 2014 Apr;17(2):159-66. doi: 10.1007/s00737-013-0394-3. Epub 2013 Nov 13. PubMed PMID: 24221408; PubMed Central PMCID: PMC3961525. Bralten J, Franke B, Waldman I, Rommelse N, Hartman C, Asherson P, Banaschewski T, Ebstein RP, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant JA, Oosterlaan J, Sonuga-Barke E, Steinhausen HC, Faraone SV, Buitelaar JK, AriasVásquez A. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2013 Nov;52(11):1204-1212.e1. doi: 10.1016/j.jaac.2013.08.020. Epub 2013 Sep 5. PubMed PMID: 24157394. van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, 15

Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W; IASP Research Group. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend. 2014 Jan 1;134:158-66. doi: 10.1016/j.drugalcdep.2013.09.026. Epub 2013 Oct 5. PubMed PMID: 24156882; PubMed Central PMCID: PMC4133781. Biederman J, Wozniak J, Tarko L, Serra G, Hernandez M, McDermott K, Woodsworth KY, Uchida M, Faraone SV. Re-examining the risk for switch from unipolar to bipolar major depressive disorder in youth with ADHD: a long term prospective longitudinal controlled study. J Affect Disord. 2014 Jan;152-154:347-51. doi: 10.1016/j.jad.2013.09.036. Epub 2013 Oct 7. PubMed PMID: 24144583; PubMed Central PMCID: PMC3867291. Faraone SV, McBurnett K, Sallee FR, Steeber J, López FA. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents. Clin Ther. 2013 Nov;35(11):1778-93. doi: 10.1016/j.clinthera.2013.09.005. Epub 2013 Oct 16. Review. PubMed PMID: 24139092. Kotte A, Faraone SV, Biederman J. Association of genetic risk severity with ADHD clinical characteristics. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):718-33. doi: 10.1002/ajmg.b.32171. PubMed PMID: 24132904. Faraone SV, Zhang-James Y. Can sodium/hydrogen exchange inhibitors be repositioned for treating attention deficit hyperactivity disorder? An in silico approach. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):711-7. doi: 10.1002/ajmg.b.32155. PubMed PMID: 24132903. Faraone SV, Seidman LJ, Buka S, Goldstein JM, Lyons M, Kremen WS, Glatt SJ. Festschrift celebrating the career of Ming T. Tsuang. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):551-8. doi: 10.1002/ajmg.b.32194. PubMed PMID: 24132890. Fliers EA, Buitelaar JK, Maras A, Bul K, Höhle E, Faraone SV, Franke B, Rommelse NN. ADHD is a risk factor for overweight and obesity in children. J Dev Behav Pediatr. 2013 Oct;34(8):566-74. doi: 10.1097/DBP.0b013e3182a50a67. PubMed PMID: 24131879; PubMed Central PMCID: PMC3859965. van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S; IASP research group, van den Brink W, Schoevers RA. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction. 2014 Feb;109(2):262-72. doi: 10.1111/add.12370. Epub 2013 Nov 20. PubMed PMID: 24118292; PubMed Central PMCID: PMC4112562. Antshel KM, Zhang-James Y, Faraone SV. The comorbidity of ADHD and autism spectrum disorder. Expert Rev Neurother. 2013 Oct;13(10):1117-28. doi: 10.1586/14737175.2013.840417. Review. PubMed PMID: 24117274. 16

Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A, Faraone SV, Biederman J. Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. J Clin Psychiatry. 2013 Sep;74(9):902-17. doi: 10.4088/JCP.12r08287. Review. PubMed PMID: 24107764; PubMed Central PMCID: PMC3801446. Faraone SV. Real progress in molecular psychiatric genetics. J Am Acad Child Adolesc Psychiatry. 2013 Oct;52(10):1006-8. doi: 10.1016/j.jaac.2013.07.014. PubMed PMID: 24074467. Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporterfunctioning: a metaanalysis. Mol Psychiatry. 2014 Aug;19(8):880-9. doi: 10.1038/mp.2013.126. Epub 2013 Sep 24. PubMed PMID: 24061496. van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MW, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, Schillinger A, Kapitány-Fövény M, Verspreet S, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Allsop S, Carruthers S, Schoevers RA; Iasp Research Group, van den Brink W. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res. 2013 Sep 11. doi: 10.1002/mpr.1397. [Epub ahead of print] PubMed PMID: 24022983; PubMed Central PMCID: PMC4085151. Kotte A, Joshi G, Fried R, Uchida M, Spencer A, Woodworth KY, Kenworthy T, Faraone SV, Biederman J. Autistic traits in children with and without ADHD. Pediatrics. 2013 Sep;132(3):e612-22. doi: 10.1542/peds.2012-3947. Epub 2013 Aug 26. PubMed PMID: 23979086; PubMed Central PMCID: PMC3876754. Manor I, Newcorn JH, Faraone SV, Adler LA. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder. Postgrad Med. 2013 Jul;125(4):181-90. doi: 10.3810/pgm.2013.07.2689. PubMed PMID: 23933905. Albayrak Ö, Pütter C, Volckmar AL, Cichon S, Hoffmann P, Nöthen MM, Jöckel KH, Schreiber S, Wichmann HE, Faraone SV, Neale BM, Herpertz-Dahlmann B, Lehmkuhl G, Sinzig J, Renner TJ, Romanos M, Warnke A, Lesch KP, Reif A, Schimmelmann BG, Scherag A, Hebebrand J, Hinney A; Psychiatric GWAS Consortium: ADHD Subgroup. Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):295-305. doi: 10.1002/ajmg.b.32144. Epub 2013 Mar 26. PubMed PMID: 23533005. Yang HC, Liu CM, Liu YL, Chen CW, Chang CC, Fann CS, Chiou JJ, Yang UC, Chen CH, Faraone SV, Tsuang MT, Hwu HG. The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population. PLoS One. 2013;8(3):e60099. doi: 10.1371/journal.pone.0060099. Epub 2013 Mar 28. PubMed PMID: 23555897; PubMed Central PMCID: PMC3610748.

17

Antshel KM, Kaul P, Biederman J, Spencer TJ, Hier BO, Hendricks K, Faraone SV. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission. J Clin Psychiatry. 2013 Mar;74(3):e197-204. doi: 10.4088/JCP.12m07698. PubMed PMID: 23561240. Hamshere ML, Langley K, Martin J, Agha SS, Stergiakouli E, Anney RJ, Buitelaar J, Faraone SV, Lesch KP, Neale BM, Franke B, Sonuga-Barke E, Asherson P, Merwood A, Kuntsi J, Medland SE, Ripke S, Steinhausen HC, Freitag C, Reif A, Renner TJ, Romanos M, Romanos J, Warnke A, Meyer J, Palmason H, Vasquez AA, Lambregts-Rommelse N, Roeyers H, Biederman J, Doyle AE, Hakonarson H, Rothenberger A, Banaschewski T, Oades RD, McGough JJ, Kent L, Williams N, Owen MJ, Holmans P, O'Donovan MC, Thapar A. High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry. 2013 Aug 1;170(8):909-16. doi: 10.1176/appi.ajp.2013.12081129. PubMed PMID: 23599091; PubMed Central PMCID: PMC3935265. Biederman J, Petty C, Spencer TJ, Woodworth KY, Bhide P, Zhu J, Faraone SV. Is ADHD a risk for posttraumatic stress disorder (PTSD)? Results from a large longitudinal study of referred children with and without ADHD. World J Biol Psychiatry. 2014 Jan;15(1):49-55. doi: 10.3109/15622975.2012.756585. Epub 2013 Apr 23. PubMed PMID: 23607442. Adler LA, Lynch LR, Shaw DM, Wallace SP, O'Donnell KE, Ciranni MA, Briggie AM, Faraone SV. Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD. J Atten Disord. 2013 May 8. [Epub ahead of print] PubMed PMID: 23657761. van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA; IASP Research Group, Levin FR. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend. 2013 Oct 1;132(3):587-96. doi: 10.1016/j.drugalcdep.2013.04.010. Epub 2013 May 6. PubMed PMID: 23660242; PubMed Central PMCID: PMC4083506. Cortese S, Faraone SV, Bernardi S, Wang S, Blanco C. Adult attention-deficit hyperactivity disorder and obesity: epidemiological study. Br J Psychiatry. 2013 Jul;203(1):24-34. doi: 10.1192/bjp.bp.112.123299. Epub 2013 May 9. PubMed PMID: 23661765; PubMed Central PMCID: PMC3696877. Liu L, Chen Y, Li H, Qian Q, Yang L, Glatt SJ, Faraone SV, Wang Y. Association between SYP with attention-deficit/hyperactivity disorder in Chinese Han subjects: differences among subtypes and genders. Psychiatry Res. 2013 Nov 30;210(1):308-14. doi: 10.1016/j.psychres.2013.04.029. Epub 2013 May 29. PubMed PMID: 23726717. Zhang-James Y, Middleton FA, Faraone SV. Genetic architecture of Wistar-Kyoto rat and spontaneously hypertensive rat substrains from different sources. Physiol Genomics. 2013 Jul 2;45(13):528-38. doi: 10.1152/physiolgenomics.00002.2013. Epub 2013 May 14. PubMed PMID: 23673728; PubMed Central PMCID: PMC3727021. 18

Yang L, Neale BM, Liu L, Lee SH, Wray NR, Ji N, Li H, Qian Q, Wang D, Li J, Faraone SV, Wang Y; Psychiatric GWAS Consortium: ADHD Subgroup, Doyle AE, Reif A, Rothenberger A, Franke B, Sonuga-Barke EJ, Steinhausen HC, Buitelaar JK, Kuntsi J, Biederman J, Lesch KP, Kent L, Asherson P, Oades RD, Loo SK, Nelson SF, Faraone SV, Smalley SL, Banaschewski T, Arias Vasquez A, Todorov A, Charach A, Miranda A, Warnke A, Thapar A, Neale BM, Cormand B, Freitag C, Mick E, Mulas F, Middleton F, HakonarsonHakonarson H, Palmason H, Schäfer H, Roeyers H, McGough JJ, Romanos J, Crosbie J, Meyer J, Ramos-Quiroga JA, Sergeant J, Elia J, Langely K, Nisenbaum L, Romanos M, Daly MJ, Ribasés M, Gill M, O'Donovan M, Owen M, Casas M, Bayés M, Lambregts-Rommelse N, Williams N, Holmans P, Anney RJ, Ebstein RP, Schachar R, Medland SE, Ripke S, Walitza S, Nguyen TT, Renner TJ, Hu X. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet. 2013 Jul;162B(5):419-30. doi: 10.1002/ajmg.b.32169. Epub 2013 May 31. PubMed PMID: 23728934. Shiffrin ND, Gruber J, Glatt SJ, Faraone SV. No association between MspI allele of the ADRA2A polymorphism and ADHD: meta-analysis of family-based studies. Psychiatr Genet. 2013 Aug;23(4):174-5. doi: 10.1097/YPG.0b013e3283631509. PubMed PMID: 23751900. Biederman J, Wozniak J, Martelon MK, Spencer TJ, Woodworth Y, Joshi G, Spencer A, Uchida M, Kotte A, Faraone SV. Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis. Psychiatry Res. 2013 Aug 15;208(3):215-24. doi: 10.1016/j.psychres.2013.05.011. Epub 2013 Jun 20. PubMed PMID: 23790757; PubMed Central PMCID: PMC3728676. Mota NR, Bau CH, Banaschewski T, Buitelaar JK, Ebstein RP, Franke B, Gill M, Kuntsi J, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant JA, Sonuga-Barke EJ, Steinhausen HC, Faraone SV, Asherson P. Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence. Am J Med Genet B Neuropsychiatr Genet. 2013 Sep;162B(6):546-9. doi: 10.1002/ajmg.b.32179. Epub 2013 Jul 2. PubMed PMID: 23818181. Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, Hartman CA, Luman M, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry. 2013 Aug;203(2):112-9. doi: 10.1192/bjp.bp.112.124784. Epub 2013 Jul 11. PubMed PMID: 23846996. Warikoo N, Faraone SV. Background, clinical features and treatment of attention deficit hyperactivity disorder in children. Expert Opin Pharmacother. 2013 Oct;14(14):1885-906. doi: 10.1517/14656566.2013.818977. Epub 2013 Jul 19. Review. PubMed PMID: 23865438. Faraone SV. Attention-deficit hyperactivity disorder and the shifting sands of psychiatric nosology. Br J Psychiatry. 2013 Aug;203(2):81-3. doi: 10.1192/bjp.bp.113.126524. PubMed PMID: 23908337.

19

Lai ZW, Borsuk R, Shadakshari A, Yu J, Dawood M, Garcia R, Francis L, Tily H, Bartos A, Faraone SV, Phillips P, Perl A. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J Immunol. 2013 Sep 1;191(5):2236-46. doi: 10.4049/jimmunol.1301005. Epub 2013 Aug 2. PubMed PMID: 23913957; PubMed Central PMCID: PMC3777662. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayés M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML,Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisén L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kähler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landén M, Långström N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Mühleisen TW, Muir WJ, Müller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nöthen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM,Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnström K, Reif A, Ribasés M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, 20

Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, Xu W, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zöllner S; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC), Devlin B, Kelsoe JR, Sklar P, Daly MJ, O'Donovan MC, Craddock N, Sullivan PF, Smoller JW, Kendler KS, Wray NR. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013 Sep;45(9):984-94. doi: 10.1038/ng.2711. Epub 2013 Aug 11. PubMed PMID: 23933821; PubMed Central PMCID: PMC3800159. Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study. Addiction. 2013 Aug;108(8):1503-11. doi: 10.1111/add.12188. Epub 2013 Apr 22. PubMed PMID: 23506232. Surman CB, Biederman J, Spencer T, Miller CA, Petty CR, Faraone SV. Neuropsychological Deficits Are Not Predictive of Deficient Emotional Self-Regulation in Adults With ADHD. J Atten Disord. 2013 Mar 15. [Epub ahead of print] PubMed PMID: 23503813. Wozniak J, Biederman J, Martelon MK, Hernandez M, Woodworth KY, Faraone SV.Does sex moderate the clinical correlates of pediatric bipolar-I disorder? Results from a large controlled family-genetic study. J Affect Disord. 2013 Jul;149(1-3):269-76. doi: 10.1016/j.jad.2013.01.040. Epub 2013 Feb 26. PubMed PMID: 23485112; PubMed Central PMCID: PMC3672385. Woodberry KA, McFarlane WR, Giuliano AJ, Verdi MB, Cook WL, Faraone SV, Seidman LJ. Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis. Schizophr Res. 2013 May;146(1-3):87-94. doi: 10.1016/j.schres.2013.01.017. Epub 2013 Feb 22. PubMed PMID: 23434505; PubMed Central PMCID: PMC3633465. Rostain A, Jensen PS, Connor DF, Miesle LM, Faraone SV. Toward Quality Care in ADHD: Defining the Goals of Treatment. J Atten Disord. 2013 Feb 19. [Epub ahead of print] PubMed PMID: 23422237. Surman CB, Biederman J, Spencer T, Miller CA, McDermott KM, Faraone SV. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. Atten Defic Hyperact Disord. 2013 Sep;5(3):273-81. doi: 10.1007/s12402-012-0100-8. Epub 2013 Feb 15. PubMed PMID: 23413201; PubMed Central PMCID: PMC4009378. Garcia RJ, Francis L, Dawood M, Lai ZW, Faraone SV, Perl A. Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum. 2013 May;65(5):1313-8. doi: 10.1002/art.37893. PubMed PMID: 23400548; PubMed Central PMCID: PMC4034122. Joshi G, Petty C, Wozniak J, Faraone SV, Spencer AE, Woodworth KY, Shelley-Abrahamson R, McKillop H, Furtak SL, Biederman J. A prospective open-label trial of paliperidone 21

monotherapy for the treatment of bipolar spectrum disorders in children and adolescents. Psychopharmacology (Berl). 2013 Jun;227(3):449-58. doi: 10.1007/s00213-013-2970-7. Epub 2013 Feb 9. PubMed PMID: 23397049. Surman CB, Hammerness PG, Pion K, Faraone SV. Do stimulants improve functioning in adults with ADHD? A review of the literature. Eur Neuropsychopharmacol. 2013 Jun;23(6):528-33. doi: 10.1016/j.euroneuro.2012.02.010. Epub 2013 Feb 4. Review. PubMed PMID: 23391411. Fried R, Petty C, Faraone SV, Hyder LL, Day H, Biederman J. Is ADHD a Risk Factor for High School Dropout? A Controlled Study. J Atten Disord. 2013 Feb 4. [Epub ahead of print] PubMed PMID: 23382575. Myles-Worsley M, Tiobech J, Browning SR, Korn J, Goodman S, Gentile K, Melhem N, Byerley W, Faraone SV, Middleton FA. Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5generation family. Am J Med Genet B Neuropsychiatr Genet. 2013 Mar;162B(2):87-95. doi: 10.1002/ajmg.b.32125. Epub 2013 Jan 22. PubMed PMID: 23341099. Antshel KM, Hendricks K, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR. The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome. J Pediatr. 2013 Jul;163(1):187-93.e1. doi: 10.1016/j.jpeds.2012.12.026. Epub 2013 Jan 18. PubMed PMID: 23337092; PubMed Central PMCID: PMC3692611. Scala S, Pousada A, Stone WS, Thermenos HW, Manschreck TC, Tsuang MT, Faraone SV, Seidman LJ. Verbal and visual-spatial memory impairment in youth at familial risk for schizophrenia or affective psychosis: a pilot study. Schizophr Res. 2013 Mar;144(1-3):1228. doi: 10.1016/j.schres.2012.11.027. Epub 2013 Jan 9. PubMed PMID: 23312552; PubMed Central PMCID: PMC3572329. Spencer TJ, Biederman J, Faraone SV, Madras BK, Bonab AA, Dougherty DD, Batchelder H, Clarke A, Fischman AJ. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry. 2013 Jul 15;74(2):84-9. doi: 10.1016/j.biopsych.2012.11.010. Epub 2012 Dec 27. PubMed PMID: 23273726; PubMed Central PMCID: PMC3700607. Yang L, Qian Q, Liu L, Li H, Faraone SV, Wang Y. Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children. J Neural Transm. 2013 Jul;120(7):1127-33. doi: 10.1007/s00702-012-0955-z. Epub 2012 Dec 25. PubMed PMID: 23266789. Lin SH, Liu CM, Hwang TJ, Hsieh MH, Hsiao PC, Faraone SV, Tsuang MT, Hwu HG, Chen WJ. Performance on the Wisconsin Card Sorting Test in families of schizophrenia patients with different familial loadings. Schizophr Bull. 2013 May;39(3):537-46. doi: 10.1093/schbul/sbs141. Epub 2012 Nov 29. PubMed PMID: 23196712; PubMed Central PMCID: PMC3627779. Biederman J, Martelon M, Faraone SV, Woodworth KY, Spencer TJ, Wozniak JR. Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a 22

controlled study. J Affect Disord. 2013 May;147(1-3):164-70. doi: 10.1016/j.jad.2012.10.028. Epub 2012 Nov 17. PubMed PMID: 23164462; PubMed Central PMCID: PMC3580118. Bloemsma JM, Boer F, Arnold R, Banaschewski T, Faraone SV, Buitelaar JK, Sergeant JA, Rommelse N, Oosterlaan J. Comorbid anxiety and neurocognitive dysfunctions in children with ADHD. Eur Child Adolesc Psychiatry. 2013 Apr;22(4):225-34. doi: 10.1007/s00787012-0339-9. Epub 2012 Oct 21. PubMed PMID: 23086381. Li Y, Baker-Ericzen M, Ji N, Chang W, Guan L, Qian Q, Zhang Y, Faraone SV, Wang Y. Do SNPs of DRD4 gene predict adult persistence of ADHD in a Chinese sample? Psychiatry Res. 2013 Jan 30;205(1-2):143-50. doi: 10.1016/j.psychres.2012.08.016. Epub 2012 Sep 29. PubMed PMID: 23031802. Biederman J, Petty CR, Spencer TJ, Woodworth KY, Bhide P, Zhu J, Faraone SV. Examining the nature of the comorbidity between pediatric attention deficit/hyperactivity disorder and post-traumatic stress disorder. Acta Psychiatr Scand. 2013 Jul;128(1):78-87. doi: 10.1111/acps.12011. Epub 2012 Sep 18. PubMed PMID: 22985097; PubMed Central PMCID: PMC3527641. Biederman J, Faraone SV, Petty C, Martelon M, Woodworth KY, Wozniak J. Further evidence that pediatric-onset bipolar disorder comorbid with ADHD represents a distinct subtype: results from a large controlled family study. J Psychiatr Res. 2013 Jan;47(1):15-22. doi: 10.1016/j.jpsychires.2012.08.002. Epub 2012 Sep 11. PubMed PMID: 22979994; PubMed Central PMCID: PMC3501568. Kuntsi J, Frazier-Wood AC, Banaschewski T, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Steinhausen HC, van der Meere JJ, Faraone SV, Asherson P, Rijsdijk F. Genetic analysis of reaction time variability: room for improvement? Psychol Med. 2013 Jun;43(6):1323-33. doi: 10.1017/S0033291712002061. Epub 2012 Sep 14. PubMed PMID: 22975296; PubMed Central PMCID: PMC3801159. Fredriksen M, Halmøy A, Faraone SV, Haavik J. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. Eur Neuropsychopharmacol. 2013 Jun;23(6):508-27. doi: 10.1016/j.euroneuro.2012.07.016. Epub 2012 Aug 20. Review. PubMed PMID: 22917983. Hammerness P, Joshi G, Doyle R, Georgiopoulos A, Geller D, Spencer T, Petty CR, Faraone SV, Biederman J. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2013 Jan;162(1):22-7.e2. doi: 10.1016/j.jpeds.2012.06.046. Epub 2012 Aug 9. PubMed PMID: 22878114. Lien YJ, Huang SS, Liu CM, Hwu HG, Faraone SV, Tsuang MT, Chen WJ. A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia. Schizophr Bull. 2013 Jan;39(1):68-76. doi: 10.1093/schbul/sbr054. Epub 2011 Jun 7. PubMed PMID: 21653277; PubMed Central PMCID: PMC3523922.

23

FREMONT, Wanda Fremont W. (2013) School Refusal in Children and Adolescents. Family Doctor A Journal of the New York State Academy of Family Physicians. 1(4).18-21. 2013. Antshel K, Faraone S, Fremont W, Hendricks K, Kates W. (2013) The Longitudinal Course of ADHD in Velo-Cardio-Facial Syndrome The Journal of Pediatrics 2013 163(1): 187-93 Ho J, Radoeva PD, Jalbrzikowski M, Chow C, Hopkins J, Tran W, Mehta, A, Enrique N, Gilbert C, Antshel K, Fremont W, Kates W, Bearden CE. Deficits in Mental State Attributions in Individuals with 22q11.2 Deletion Syndrome (Velo-Cardio-Facial Syndrome). Autism Res (In press). GLATT, Stephen J. Tylee DS, Kawaguchi DM, & Glatt SJ (2013) On the outside, looking in: A review and evaluation of the comparability of blood and brain “-omes”. American Journal of Medical Genetics B Neuropsychiatric Genetics, 162(7):595-603. Glatt SJ, Tylee D, Chandler SD, Pazol J, Nievergelt CM, Woelk CH, Baker DG, Lohr JB, Kremen WS, Litz BT, Marine Resiliency Study Investigators, & Tsuang MT (2013) Bloodbased gene-expression predictors of PTSD risk and resilience among deployed Marines: A pilot study. American Journal of Medical Genetics B Neuropsychiatric Genetics, 162(4):313-326. Bulayeva K, Glatt S, Walsh C, Gurgenova F, Berdichevets I, Bulayev O, & Thompson (in press) Significant linkage and structural genomic variants at 12q24.21-q24.32 found in genetic isolate with aggregation of unspecific mental retardation. Open Journal of Genomics. Liu L, Chen Y, Li H, Qian Q, Yang L, Glatt SJ, Faraone SV, Wang Y (2013) Association between SYP with attention-deficit/hyperactivity disorder in Chinese Han subjects: Differences among subtypes and genders. Psychiatry Research, S0165-1781(13): 257-256. Shiffrin ND, Gruber J, Glatt SJ, Faraone SV (2013) No association between MspI allele of the ADRA2A polymorphism and ADHD: meta-analysis of family-based studies. Psychiatric Genetics, 23(4):174-175. Glatt SJ (2013) How should we interpret and value the pursuit of blood-based biomarkers for autism spectrum disorders? Journal of the American Academy of Child & Adolescent Psychiatry, 52(12):1248-1250. Cohen OS, Varlinskaya EI, Wilson CA, Glatt SJ, & Mooney SM (2013) Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. International Journal of Developmental Neuroscience. 31(8):740-750. GREENBERG, Roger

24

Greenberg, R.P. (2013). Rejuvenating psychotherapy: Science battles business. (A review of Refocused Psychotherapy). PsycCRITIQUES-Contemporary Psychology: APA Review of Books. DeGeorge, J., Constantino, M.J., Greenberg, R.P., Swift, J.K. & Smith Hansen, L. (2013). Sex differences in college students’ preferences for an ideal psychotherapist. Professional Psychology: Research and Practice 44, 29-36. GREGORY, Robert J. Leontieva L, Gregory RJ (2013) Characteristics of patients with borderline personality disorder in a state psychiatric hospital. Journal of Personality Disorders. 27:222232. PMID: 23514185 Sachdeva S, Goldman G, Mustata G, Deranja E, Gregory RJ: Naturalistic outcomes of evidence-based therapies for borderline personality disorder at a university clinic: A quasi-randomized trial. Journal of the American Psychoanalytic Association. 61:578584. PMID: 2372002 JOHNSON, Brian Johnson B., Faraone SV. Outpatient detoxification completion and one month outcomes for opioid dependence: A preliminary open label study of a neuropsychoanalytic treatment in pain patients and addicted patients, Neuropsychoanalysis 2013;15:145-60. Johnson B. Addiction and will. Frontiers in Human Neuroscience 2013;7:545. Doi 10.3389/fnhum Johnson B., Streltzer J. Risks associated with long term benzodiazepine use. EditorialAmerican Family Practice. 2013;88(4):224-6. van Emmerik-van Oortmerssen K, van de Glind G, Koeter MWJ, Allsop S, Barta C, Bu ETH, Carpentier PJ, Carruthers S, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR , Moggi F, RamosQuiroga A, Schillinger A, Seitz A, Skutle A, Verspreet S, IASP research group, van den Brink W, Schoevers RA. Comorbidity as a rule. Psychopathological characteristics of treatment seeking SUD patients with and without ADHD: results of the IASP study. Addiction 2013;doi:10.1111/add12370. Verspreet S, IASP research group, van den Brink W, Schoevers RA, van de Glind G; Koeter MWJ; Carpentier PJ; van Emmerik- van Oortmerssen K; Kaye S; Skutle A; Bu ETH; Franck J; Konstenius M; Moggi F; Dom G; Verspreet S; Demetrovics Z; KapitanyFoveny M; Fatseas M; Auriacombe M; Schillinger A; Seitz A; Johnson B; Faraone SV; J Ramos-Quiroga A; Casas M; Allsop S; Carruthers S; Barta C; Levin FR. Validity of the Adult ADHD Self-report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence 2013;132(3):587-96. 25

van de Glind G, Konstenius M, Levin FR, Koeter MWJ, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ETH, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatseas M, Auriacombe M, Schillinger A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, IASP research group, van den Brink W. The International ADHD in Substance use disorders Prevalence (IASP) study: background, methods and study population International Journal of Methods in Psychiatric Research 2013;doi:10.1002/mpr.1397 KATES, Wendy R. Antshel KM, Hendricks K, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR. (2013). The longitudinal course of attention deficit/hyperactivity disorder in velo-cardiofacial syndrome. J Pediatr 163(1):187-93. PMID: 23337092. Delio M, Guo T, McDonald-McGinn DM, Zackai E, Herman S, Kaminetzky M, Higgins AM, Coleman K, Chow C, Jalbrzikowski M, Bearden CE, Bailey A, Vangkilde A, Olsen L, Olesen C, Skovby F, Werge TM, Templin L, Busa T, Philip N, Swillen A, Vermeesch JR, Devriendt K, Schneider M, Dahoun S, Eliez S, Schoch K, Hooper SR, Shashi V, Samanich J, Marion R, van Amelsvoort T, Boot E, Klaassen P, Duijff SN, Vorstman J, Yuen T, Silversides C, Chow E, Bassett A, Frisch A, Weizman A, Gothelf D, Niarchou M, van den Bree M, Owen MJ, Suñer DH, Andreo JR, Armando M, Vicari S, Digilio MC, Auton A, Kates WR, Wang T, Shprintzen RJ, Emanuel BS, Morrow BE. (2013). Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J. Hum Genet. 92(3): 439–447. PMID: 23453669. Perlstein, MD, Chohan MR, Coman IL, Antshel KM, Fremont WP, Gnirke MH, Kikinis Z, Middleton FA, Radoeva PD, Shenton ME, Kates WR. (2014; Epub 2013). White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis. Schizophr Res. 152(1):117-23. PMID: 24321711. Herman SB, Guo T, McGinn DM, Blonska A, Shanske AL, Bassett AS, Chow EW, Bowser M, Sheridan M, Beemer F, Devriendt K, Swillen A, Breckpot J, Digilio MC, Marino B, Dallapiccola B, Carpenter C, Zheng X, Johnson J, Chung J, Higgins AM, Philip N, Simon T, Coleman K, Heine-Suner D, Rosell J, Kates W, Devoto M, Zackai E, Wang T, Shprintzen R, Emanuel BS, Morrow BE; International Chromosome 22q11.2 Consortium. (2012). Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardiofacial/DiGeorge/22q11.2 deletion syndrome patients. Am J Med Genet A. 158A(11): 27812787. PMID: 23034814. Hettema JM, Kettenmann B, Ahluwalia V, McCarthy C, Kates WR, Schmitt JE, Silberg JL, Neale MC, Kendler KS, Fatouros P. (2012). Pilot multimodal twin study of generalized anxiety disorder. Depress Anxiety. 3: 202-209. PMID: 21994092 Ho JS, Radoeva PD, Jalbrzikowski M, Chow C, Hopkins J, Tran WC, Mehta A, Enrique N, Gilbert C, Antshel KM, Fremont W, Kates WR, Bearden CE. (2012). Deficits in mental state attributions in individuals with 22q11.2 deletion syndrome (velo-cardio-facial syndrome). Autism Res. 5(6):407-18. PMID: 22962003 26

Kunwar A, Ramanathan S, Nelson J, Antshel KM, Fremont W, Higgins AM, Shprintzen RJ, Kates WR. (2012). Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study. Schizophr Res. 137(1-3): 20-25. PMID: 22365148. Radoeva PD, Coman IL, Antshel KM, Fremont W, McCarthy CS, Kotkar A, Wang D, Shprintzen RJ, Kates WR. (2012). Atlas-based white matter analysis in individuals with velo-cardio-facial syndrome (22q11.2 deletion syndrome) and unaffected siblings. Behav Brain Funct. 8:38. PMID: 22853778. KAUFMAN, Andrew Way BB, Kaufman AR, Knoll JL, Chlebowski, S: Suicidal Ideation among Inmate-Patients in State Prison: Prevalence, Reluctance to Report, and Treatment Preferences. Behavioral Science and the Law, 31(2): 230-8, 2013. KNOLL, James Way B, Kaufman A, Knoll J, Chlebowski S: Suicidal Ideation among Inmate-Patients in State Prison: Prevalence, Reluctance to Report, and Treatment Preferences. Behavioral Sciences & the Law, 2013 Knoll J: Drugging Aggression Behind Bars. Correctional Mental Health Report. (2013), 15(2): 17, 29-31. Knoll J: Warning: Antidepressants May Cause Bank Robbery. Psychiatric Times, November 2013. Knoll J: The Rebirth of the Mind. Psychiatric Times, April 2013. Knoll J: Mass Shootings: Research & Lessons. Psychiatric Times, February, 2013. Knoll J: The Older Psychiatrist in an Era of “Unprecedented Change.” Psychiatric Times, January, 2013 Knoll J: Tales from the New Asylum: Truth? Psychiatric Times Blog, September, 2013 Knoll J: Parkland Still. Psychiatric Times. November, 2013. Knoll J: The Return of the Alienist. Medscape. May 10, 2013 Knoll J: Lighting a Candle in Newtown. Psychiatric Times. April, 2013 Knoll J: Mass Distractions. Medscape. February 14, 2013 MEGNA, James

27

Bedynerman K, Megna JL. (2013) Pharmacokinetic Properties of Second Generation Antipsychotics. In Antipsychotic Drugs: Pharmacology, Side Effects, and Abuse Prevention. Editors: Thomas L. Schwartz, James L. Megna, and Michael F. Topel. Nova Science Publishers, Inc. pp. 45-54. Iqbal MM, Herrera-Rojas M, Megna JL. (2013) Clozapine: Adverse Effects and Their Management. In Antipsychotic Drugs: Pharmacology, Side Effects, and Abuse Prevention. Editors: Thomas L. Schwartz, James L. Megna, and Michael F. Topel. Nova Science Publishers, Inc. pp. 287-314. Books Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention. Editors: Thomas L. Schwartz, James L. Megna, Michael F Topel. Nova Science Publishers, Inc. (2013)

MESZAROS, Zsuzsa Mészáros Z.S., Abdul-Malak Y., Dimmock J.A., Wang, D., Ajagbe T.O., Batki S.L. (2013) Varenicline treatment of alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial. The Journal of Clinical Psychopharmacology. 33(2):243-7. doi: 10.1097/JCP.0b013e3182870551. O’NEILL, Richard O’Neill, R.M., Gantt, S.P., Burlingame, G.M., Mogle, J., Johnson, J., & Silver, R. (2013). Development of the SCT® Functional Subgrouping Questionnaire-2. Group Dynamics: Theory, Research and Practice, 17, 252-269. O’Neill, R.M., Murphy, V., Mogle, J., MacKenzie, M.J., MacGregor, K.L., Pearson, M., & Parekh, M. (2013). Are Systems-Centered®¹ teams more collaborative, productive and creative? Journal of Team Performance Management, 19 (3/4), 201-221. PIES, Ronald Iltis AS, Misra S, Dunn LB, Brown GK, Campbell A, Earll SA, Glowinski A, Hadley WB, Pies R, Dubois JM. (2013) Addressing risks to advance mental health research.JAMA Psychiatry.70(12):1363-71. PMID: 24173618 Zisook S, Pies R, Iglewicz A. (2013) Grief, depression, and the DSM-5. J Psychiatr Pract. 19(5):386-96. PMID: 24042244 SCHWARTZ, Thomas BOOKS Edited: 28

Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, TL Schwartz, J Megna, M Topel Editors Nova Scientific Publishing:New York, 2013. Journal Articles: Warikoo N, Schwartz TS, Citrome L. Depot Antipsychotics in Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, Schwartz, Megna, Topel (eds.) Nova Scientific Publishing, 2013. Poovilingham K, Schwartz TS. Sedating Side Effects of Atypical Antipsychotics. in Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, Schwartz, Megna, Topel (eds.) Nova Scientific Publishing, 2013. Warikoo N, Schwartz TS, Citrome L. Tardive Dyskinesia in Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, Schwartz, Megna, Topel (eds.) Nova Scientific Publishing, 2013. Schwartz TL, Siddiqui U, Stahl SM. Translating Basic Science into Clinical Practice while Dosing the Second Generation Antipsychotics in Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, Schwartz, Megna, Topel (eds.) Nova Scientific Publishing, 2013. Schwartz TL. Psychopharmacological practice: The DSM versus The Brain Mens Sana Monographs. 2013:11(1); 25-41. Schwartz TL, Goradia V. Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon. Drugs in Context 2013; 212257. doi: 10.7573/dic.212257 Schwartz TL. A neuroscientific update on monoamine oxidase and its inhibitors. CNS Spectrums 2013:18;25-33.

TRIEF, Paula M. Saletsky R, Trief PM, Anderson BJ, Rosenbaum P, Weinstock RS. Parenting style, parent-youth conflict, and medication adherence in youth with type 2 diabetes participating in an intensive lifestyle change intervention. Families, Systems & Health, 2/17/14, DOI – 10.1037/fsh0000008, [epub ahead of print] PubMed # 24548045 NIHMSID #555681 Weinstock RS, Trief, PM, Cibula D, Morin P, Delahanty L. Weight loss success in metabolic syndrome by telephone interventions: Results from the SHINE Study. J Gen Int Med 2013; July 11, epub ahead of print Schrimpf L, Trief P. Emotional Intelligence and psychiatry residents: Does the PRITE measure Emotional Intelligence? Acad Psychiatry 2013;37(5): 339-341

29

Trief PM, Sandberg JG, Dimmock JA, Forken PJ, Weinstock RS. Personal and relationship challenges of adults with type 1 diabetes: A qualitative focus group study. Diabetes Care 2013;36:2483-2488

30

Presentations (National or International Conferences) FARAONE, Stephen Faraone, SV. Update on the Neurobiology of ADHD. Grand Rounds, Hospital General, Universitario Gregorio Maranon, Madrid, Spain. September 2013. Faraone, SV. Genetics of ADHD and Autism. World Congress of Psychiatric Genetics, Boston, MA. October 2013. Faraone, SV. New Data about the Genetics of Attention Deficit Hyperactivity Disorder. World Congress of Psychiatric Genetics, Boston, MA. October 2013. Faraone, SV. Update on Genomewide Studies of Attention Deficit Hyperactivity Disorder. Seminar, Karolinska Institute, Stockholm, Sweden. November 2013. Faraone, SV. ADHD in girls for ADHD. Keynote Talk, CME Program, London, UK. November 2013. FREMONT, Wanda Sharma V, Galanter C, Jensen P, Fornari V, Fremont W, Scharf, M, Zuckerbrot R, Cogswell A, Foley C, Hargrave T, Wallace J, Smoth B, Bhatia I, Kaye D. Pediatricians and Primary Care Physician’s Knowledge, Comfort, and Practices About Children’s Mental Health Before and After a Theory-Based Training. Research Poster. 60th Annual Meeting of the Academy of Child and Adolescent Psychiatry, Orlando, Florida.. Oct 2013. Fornari V, Scharf M, Fremont W, Zuckerbrot R, Foley C, Hargrave T, Smith B, Wallace J, Galanter C, Cogswell A, Bhatia I, Jensen P. The Evolution of Child and Adolescent Psychiatry Primary Care: New York State-University Collaborative Consultation Program for Primary Care. 60th Annual Meeting of the Academy of Child and Adolescent Psychiatry, Orlando, Florida. Oct 2013 Hargrave, Teresa, Fremont W, Cogswell A. Outreach Helps: Child Psychiatry to Primary Care. Research Poster. 60th Annual Meeting of the Academy of Child and Adolescent Psychiatry, Orlando, Florida. Oct 2013 GLATT, Stephen J. Glatt, SJ. (2013) Blood-Based Gene-Expression Predictors of PTSD Risk and Resilience among Deployed Marines: A Pilot Study. 43rd Annual Meeting of the ISPNE; Leiden, The Netherlands August 22, 2013. Glatt, SJ. Replication and Extension of Blood-Based Biomarkers and Classifiers of Autism Spectrum Disorders, Developmental and Language Delays, and Typical Development. WCPG XXI; Boston, MA October 18, 2013. 31

Glatt, SJ. Interactions among Candidate SNPs for ADHD and Schizophrenia: Comparison of Family-Based and Case-Control Methods. WCPG XXI; Boston, MA October 18, 2013. Glatt, SJ. Blood-Based Gene-Expression Predictors of PTSD Risk and Resilience among Deployed Marines. 52nd Annual Meeting of the American College of Neuropsychopharmacology; Hollywood, FL. December 10, 2013. Glatt, SJ. PTSD Markers of Disease: Genetics, Epigenetics and Genomics; BIOSTRESS.MIL, The Use of Biomarkers in the Military: From PTSD Susceptibility to Disease; International Society of Psychoneuroendocrinology (ISPNE) Satellite Symposium; Royal Marine Base; Amsterdam, The Netherlands. August 23, 2013. GREENBERG, Roger Swift, J.K. & Greenberg, R.P. (2013). “Do Treatments Differ in their Dropout Rates? Results from Two Meta-Analyses.” Society for the Exploration of Psychotherapy Integration, Annual Meeting. Barcelona, Spain, June 7, 2013. GREGORY, Robert Sachdeva S, Goldmann GA, Mustata GT, Deranja EO, Gregory RJ. (2013). Naturalistic outcomes of evidence-based therapies for borderline personality disorder at a university clinic: A quasi-randomized trial. Poster presentation at the Annual Meeting of the American Psychoanalytic Association, New York, NY, January 18, 2013 HARGRAVE, Teresa Hargrave TM, Crawford JA, Rosenbaum PF, Abraham JL and Hunt A “Prenatal Psychosocial Risk Factors and Repeat Wheeze in the First Year of Life” Poster Presentation at APA Meeting in San Francisco, May 19, 2013 Sharma V, Galanter C, Jensen P, Fornari V, Fremont W, Scharf, M, Zuckerbrot R, Cogswell A, Foley C, Hargrave T, Wallace J, Smoth B, Bhatia I, Kaye D. Pediatricians and Primary Care Physician’s Knowledge, Comfort, and Practices About Children’s Mental Health before and After a Theory-Based Training. 2013 Research Poster. 60th Annual Meeting of the Academy of Child and Adolescent Psychiatry, Orlando, Florida. Fornari V, Scharf M, Fremont W, Zuckerbrot R, Foley C, Hargrave T, Smith B, Wallace J, Galanter C, Cogswell A, Bhatia I, Jensen P. The Evolution of Child and Adolescent Psychiatry Primary Care: New York State-University Collaborative Consultation Program for Primary Care. 2013 60th Annual Meeting of the Academy of Child and Adolescent Psychiatry, Orlando, Florida Hargrave, Teresa, Fremont W, Cogswell A. Outreach Helps: Child Psychiatry to Primary Care.Research Poster. 2013 60th Annual Meeting of the Academy of Child and Adolescent Psychiatry, Orlando, Florida 32

JOHNSON, Brian Johnson, B. “Making Relatedness a Treatment Goal,” Georgia Psychiatric Physicians Association. February 16, 2013. Johnson, B. “Neurobiology of Cathexis,” Atlanta Psychoanalytic Society. February 15, 2013. KATES, Wendy Kates, W.R., Faraone, S.V., Antshel, K.M. Fremont, W. “Longitudinal Trajectories of Neuroanatomy in 22q11.2 Deletion Syndrome: Can We Predict the Schizophrenia Prodrome?”, presented to the International Congress on Schizophrenia Research, Orlando, FL, April, 2013. Kates, W.R., Faraone, S.V., Antshel, K.M. Fremont, W. “Longitudinal Trajectories of Neuroanatomy in 22q11.2 Deletion Syndrome: Can We Predict the Schizophrenia Prodrome?”, presented to the Meeting of the Society of Biological Psychiatry, San Francisco, CA, May, 2013. Kates, W.R., Wood, W.M., Fremont, W., Faraone, S.V., Russo, N., Antshel, K.M. “Moderators of Pscyiatric Risk in VCFS: A Longitudinal Study”, presented to the 20th Annual International Scientific Meeting of The Velo-Cardio-Facial Syndrome Educational Foundation, Dublin Ireland, July, 2013. Kates, W.R., Perlstein, M.D., Chohan, M., Radoeva, P., Antshel, K.M. Fremont, W., Coman, I., Middleton, F “Associations between Allelic Variation in NoGo-66 Receptor and White Matter Integrity in VCFS / 22q11.2 Deletion Syndrome”, presented to the 20th Annual International Scientific Meeting of The Velo-Cardio-Facial Syndrome Educational Foundation, Dublin Ireland, July, 2013. INVITED PRESENTATIONS: Kates, W.R. “Risk for Psychosis in Velo-cardio-facial Syndrome”, presented to the Child Psychiatry Grand Rounds, Sheba Medical Center, Tel Hashomer, Israel, December, 2013. KAUFMAN, Andrew Kaufman, A.R. What Should Forensic Psychiatry Fellows Learn About Research. American Academy of Psychiatry and the Law (San Diego, CA), October 2013. KNOLL, James Knoll, J. Antisocial Personality DisorderGeorgia Psychiatric Physicians AssociationAtlanta, Georgia. February 15, 2013

33

Knoll, J. Mass Murder & Mental Illness (Debate) American Academy of Psychiatry and the Law, 44th Annual Meeting; San Diego, CA October 24, 2013 Knoll, J. The Sadistic Symbiosis of Sadist & Spouse (scientific poster presentation) October 24, 2013 Knoll, J. Breivik – Extreme Ideologist or Mentally Deranged? American Academy of Psychiatry and the Law,44th Annual Meeting; San Diego, CA October 25, 2013 Knoll, J. Breivik: All-Consuming Hatred Approaching Psychosis? Co-presented with Terje Torrissen, M.D., October 25, 2013 (Breivik forensic evaluator from Norway) Knoll, J. Forensic Psychiatric Consulting for Crisis Negotiation (scientific poster presentation) American Academy of Psychiatry and the Law, 44th Annual Meeting; San Diego, CA October 26, 2013 Knoll, J. Not Guilty By Reason of Medication: Your Drugs Made Me Do It American Academy of Psychiatry and the Law, 44th Annual Meeting; San Diego, CA October 27, 2013 Knoll, J. What is Forensic Psychiatry? National Alliance on Mental Illness (NAMI) Educational Conference; Syracuse, NY October 10, 2013 MESZAROS, Zsuzsa Mészáros Z.S. (2013) Functional Neuroimaging in Addiction. Chair of Symposium and invited speaker at American Academy of Addiction Psychiatry 24th Annual Meeting and Symposium Scottsdale, AZ, 12/6/2013 Mészáros Z.S. (2013) Smoking Severity and Functional Neuroimaging in Schizophrenia. Invited lecture at the Neuroscience Research on Substance Abuse Conference. Buffalo, NY, 9/28/2013 MILLER, Michael Miller, M. (2013) Master class in Lacanian psychotherapy. Master class presented to the Advanced Training Program in Psychoanalytic Psychotherapy. 4/11/2013, Toronto Psychoanalytic Society and Institute. Toronto, Ontario, Canada. Miller, M. (2013) Listening Closely: The clinical Lacan. Invited address: 38th Annual Scientific Session of the Advanced Training Program in Psychoanalytic Psychotherapy, 4/12/2013, Toronto Psychoanalytic Society and Institute, Toronto, Ontario, Canada. Miller, M. (2013) Case Commentary: Une Femme de Valeur; and Responses to Questions for the Author. Invited address: LacanToronto. 4/13/2013, Toronto Psychoanalytic Society and Institute, Toronto, Ontario, Canada.

34

O’NEILL, Richard O’Neill, R.M. (2013). The latest on SCT research: The large group. 14th Annual International Conference of the Systems-Centered Training and Research Institute, Philadelphia, PA, April 16. SCHWARTZ, Thomas Schwartz TL. (2013) Depression. 3rd Annual Hot Topics in Primary Care Symposium, Guthrie, PA Schwartz TL. (2013) Depression Up Date. Pri-Med Conference. New York, Chicago Schwartz TL. (2013) Waking Up to Treatment Guidelines for Shift Work Disorder. Neuroscience Education Institute Congress. Colorado Springs, CO. Schwartz TL (2013) Treatment Resistant Depression: New Developments in Switching Strategies and Augmentation Major Depressive Disorder Summit Philadelphia, PA TRIEF, Paula M. Trief PM. Couples therapy and diabetes. Audio interview. Diabetes Insight, 2013, Sept.: 4(18) Trief PM, Xing D, Kittelsrud J, Olson BA, Young L, Peters AL, Miller KM, Beck RW, Weinstock RS. Depression in Adults with Type 1 Diabetes Participating in the T1D Exchange Clinic Registry. Poster presented at the Annual Meeting of the American Diabetes Association, June, 2013, Chicago IL. Trief PM, Jiang Y, Beck RW, Goldman DP, Huckfeldt PJ, Knight TK, Miller KM, Weinstock RS. Adults with T1D: Partner Relationships and Outcomes. Poster Presented at the Annual Meeting of the American Diabetes Association, June, 2013, Chicago IL. Ulbrecht J, Trief PM, Wallston K, Smyth J. Short-Term Effects of Expressive Writing as Adjuvant Treatment in T2DM on Clinical Status and Patient Well-Being. New Findings From Controlled Behavioral Interventions. Oral presentation at the Annual Meeting of the American Diabetes Association, June, 2013, Chicago IL. Trief PM. Weight Loss in Primary Care: 2 Year Results of the SHINE DPP Telephone Translation. New Findings from Controlled Behavioral Interventions. Oral presentation at the Annual Meeting of the American Diabetes Association, June, 2013, Chicago IL. Trief PM. Couples vs. Individual Interventions for Diabetes: New Insights. Invited Speaker. Behavioral Interventions for Diabetes: Evidence from Recent Intervention Studies. Presented at the Annual Meeting of the American Diabetes Association, June, 2013, Chicago, IL

35

Trief PM. Issues Facing Adults and Their Families Living with T1D. Invited KOL (Key Opinion Leader) to present to leadership of JDRF as part of strategic planning around how JDRF can address the psychosocial burden of type 1 diabetes across the lifespan. Feb. 21-22, 2013, New York, NY Trief PM. Development of a Couples Intervention for Adults with Type 1 Diabetes. Presented At the 27th Annual Conference of the Behavioral Research In Diabetes Group Exchange (BRIDGE), Tucson AZ, Feb. 8, 2013

36